Investments and Other Marketable Securities (Tables)

3 Months Ended

Mar. 31, 2025

Marketable Securities [Abstract]

Schedule of Investments

Investments on the accompanying Consolidated Balance Sheets consist of:

	March 31, 2025		December 31, 2024
Available for sale and equity securities	$	206,214	$	183,656
Investments in affiliated funds	8,148		8,129
Investments in limited partnership funds	566		—
Equity method investments (See Note 2)	63,156		123,782
Total	$	278,084	$	315,567

Schedule of Available For Sale and Equity Securities

Available for sale and equity securities consist of: 

	At March 31, 2025
	Cost Amount		Gross Unrealized Gains		Gross Unrealized (Losses)		Fair Value
Available-for-sale debt securities	$	171,780	$	—	$	(7,099)	$	164,681
SEI-sponsored investment products	33,569		1,944		—		35,513
Equities and other investment products	5,842		178		—		6,020
	$	211,191	$	2,122	$	(7,099)	$	206,214

	At December 31, 2024
	Cost Amount		Gross Unrealized Gains		Gross Unrealized (Losses)		Fair Value
Available-for-sale debt securities	$	154,211	$	—	$	(11,085)	$	143,126
SEI-sponsored investment products	33,029		1,615		—		34,644
Equities and other investment products	5,554		332		—		5,886
	$	192,794	$	1,947	$	(11,085)	$	183,656

Schedule of Available-for-Sale Debt Securities by Maturity

The following tables provide the scheduled maturities of the Company's available-for-sale debt securities:

	At March 31, 2025
	Cost		Fair Value
Within one year	$	—	$	—
After one year through five years	3,602		3,285
After 5 years through 10 years	19,218		17,698
After 10 years	148,960		143,698
	$	171,780	$	164,681

	At December 31, 2024
	Cost		Fair Value
Within one year	$	—	$	—
After one year through five years	4,132		3,763
After 5 years through 10 years	20,323		18,429
After 10 years	129,756		120,934
	$	154,211	$	143,126